Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'

The drugmaker, along with partner Regeneron, is studying whether Kevzara can ease the severe respiratory symptoms experienced by some patients.

Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'
The drugmaker, along with partner Regeneron, is studying whether Kevzara can ease the severe respiratory symptoms experienced by some patients.